7 completed, 2 terminated. 7 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Terminated 2 |
Follow phosphomannopentaose sulfate: new trials by email Literature Review of phosphomannopentaose sulfate trials Research Report on phosphomannopentaose sulfate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection PI-88, Placebo - Cancer, Liver Cancer | Phase 3 | Terminated | Cellxpert Biotechnology Corp. | 520 | 2011-08-01 | 2022-06-23 |
| Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma PI-88, placebo - Cancer, Liver Cancer | Phase 3 | Terminated | Progen Pharmaceuticals | 600 | 2007-12-01 | 2011-06-15 |
| Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer PI-88, docetaxel, prednisone - Prostate Cancer | Phase 2 | Completed | Progen Pharmaceuticals | 48 | 2005-08-01 | 2011-06-15 |
| Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma PI-88 and dacarbazine, dacarbazine or DTIC - Melanoma | Phase 2 | Completed | Cellxpert Biotechnology Corp. | 134 | 2005-06-01 | 2022-06-23 |
| PI-88 in Hepatocellular Carcinoma After Hepatectomy PI-88 - Carcinoma, Hepatocellular | Phase 2 | Completed | Cellxpert Biotechnology Corp. | 172 | 2004-06-01 | 2022-06-23 |
| Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer PI-88, docetaxel - Lung Cancer | Phase 2 | Completed | Cellxpert Biotechnology Corp. | 98 | 2004-02-01 | 2022-06-27 |
| Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC) docetaxel, PI-88 - Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | Cellxpert Biotechnology Corp. | 100 | 2004-02-01 | 2022-06-27 |
| PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma PI-88 - Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 / Phase 2 | Completed | Cellxpert Biotechnology Corp. | 44 | 2004-01-01 | 2022-06-27 |
| Study of PI-88 in Patients With Advanced Melanoma PI-88 - Melanoma | Phase 1 / Phase 2 | Completed | Cellxpert Biotechnology Corp. | 88 | 2001-07-01 | 2022-06-27 |
Carcinoma, Hepatocellular (3) · Melanoma (3) · Carcinoma, Non-Small-Cell Lung (2) · Liver Neoplasms (2) · Neoplasms (2) · Lung Neoplasms (1) · Prostatic Neoplasms (1)
Cellxpert Biotechnology Corp. (7) · Progen Pharmaceuticals (2)
Australia (6) · United States (4) · Taiwan (3) · Hong Kong (2) · Canada (1) · China (1) · Italy (1) · Malaysia (1) · Singapore (1) · South Korea (1) · Spain (1) · Thailand (1)
Nick Pavlakis, MD (3) · Anne Hamilton, PhD (1) · Damien Thomson, MD (1) · Gavin Marx, MD (1) · Michael Millward, MD (1) · Paul Mitchell, MD (1) · Pei-Jer Chen, MD (1) · Pei-Jer Chen, MD, PhD (1) · Ronnie TP Poon, MD (1) · S. G. Eckhardt, MD (1)